- Category: HIV Disease Progression - Published on Thursday, 22
March 2012 00:00 - Written by Press Release HIV-infected infants
who start antiretroviral therapy (ART) immediately after birth
can interrupt treatment after 1-2 years and still do better than
babies who delayed ART initiation until they developed symptoms,
researchers reported at the 19th Conference on Retroviruses and
Opportunistic Infections (CROI 2012) this month in Seattle. A
related study found that among children older than 1 year who
were not diagnosed as HIV-infected HIV at birth, those who
started ART at the time of diagnosis and those who waited until
they showed symptoms had similar rates of neurocognitive and
behavior problems, but both groups were at higher risk than
children who were diagnosed and started therapy soon after
birth. Below is an edited excerpt from a media announcement
issued by the National Institutes of Health, which funded the
CHER and PREDICT studies, describing the findings presented at
CROI. NIH-Funded Studies S